These findings suggest that TGF-β1/Smads may have a primary regulatory effect on the NF-κB p65 pathway and that BBR may primarily inhibit the expression of NF-κB p65 by suppressing the TGF-β1/Smad pathway, thereby regulating the EMT of colorectal cancer cells. This evidence concerns the gene NFKB1 and colorectal cancer.